THE DUTY TO COUNSEL - REVIEWING A DECADE OF LITIGATION

被引:6
作者
BRUSHWOOD, DB
机构
[1] College of Pharmacy, University of Florida, Gainesville
来源
DICP-THE ANNALS OF PHARMACOTHERAPY | 1991年 / 25卷 / 02期
关键词
D O I
10.1177/106002809102500217
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Twenty-three legal cases from the 1980s were studied. The allegation in each of these cases was that the defendant pharmacist should have done something more than correctly process a prescription to prevent harm to the patient from drug use. Four theoretical models of pharmacist legal responsibility are considered: (1) the policy-analysis model, (2) the professional-standards model, (3) the consumer-expectation model, and (4) the power model. It is concluded that the power model, based on superior knowledge and reasonable foreseeability of harm, best defines the pharmacist's legal responsibility, consistent with established legal precedents.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 9 条
[1]  
FINK JL, 1977, J CONTIN ED PHARM, V1, P65
[2]  
JOYCE G, 1988, J PHARM MARK MANAGE, V3, P3
[3]  
Keeton W. Page, 1984, PROSSER KEETON TORTS, P373
[4]   PHARMACISTS DUTY TO WARN PATIENT OF SIDE-EFFECTS OF DRUGS [J].
SALISBURY, R .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1977, 17 (02) :97-100
[5]  
SPAULDING CD, 1989, J PHARM MARKET MANAG, V3, P73
[6]  
Starr Paul, 1982, SOCIAL TRANSFORMATIO, P21
[7]  
VANDALL FJ, 1986, U TOLEDO LAW REV, V18, P20
[8]  
VANDERVUSSE GJ, 1986, EUR SURG RES, V18, P1, DOI 10.1159/000128499
[9]  
1983, NATIONAL PRESCRIPTIO, P21